- TRADE NAMES: CellCept (Roche); Myfortic (Novartis)
- INDICATIONS: Prophylaxis of organ rejection
- SYNONYM: mycophenolate mofetil, mycophenolate sodium, mycophenolic acid
- CLASS: Immunosuppressant
- HALF-LIFE: 18 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Antacids, Azathioprine, Basiliximab, Belatacept, Cholestyramine, Ciprofloxacin, Corticosteroids, Cyclophosphamide, Cyclosporine, Daclizumab, Gemifloxacin, Hemophilus B Vaccine, Levofloxacin, Mercaptopurine, Metronidazole, Moxifloxacin, Norfloxacin, Ofloxacin, Pantoprazole, Rifapentine, Sevelamer, Tacrolimus, Vaccines
EMBRYOFETAL TOXICITY, MALIGNANCIES AND SERIOUS INFECTIONS
See full prescribing information for complete boxed warning.
Please login to view the rest of this drug profile.
DRUG REVIEW ARTICLE
Click on the DRUG REVIEW ARTICLE tab (above) to see a review of mycophenolate in the Taylor & Francis journal Expert Opinion on Drug Safety.
(Note that non-subscribers to the journal will only be able to see an abstract of the article.)
Page last updated 01/04/2025